Kin Tang

533 total citations
14 papers, 255 citations indexed

About

Kin Tang is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Kin Tang has authored 14 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Economics and Econometrics. Recurrent topics in Kin Tang's work include Drug Solubulity and Delivery Systems (7 papers), Crystallization and Solubility Studies (3 papers) and Pharmaceutical studies and practices (3 papers). Kin Tang is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Crystallization and Solubility Studies (3 papers) and Pharmaceutical studies and practices (3 papers). Kin Tang collaborates with scholars based in United States, United Kingdom and Switzerland. Kin Tang's co-authors include Hitesh Chokshi, Jennifer Dressman, Ekarat Jantratid, Neil Parrott, Nikoletta Fotaki, Christos Reppas, Long Chiau Ming, Antonio Albano, Shalini Anand and Waseem Malick and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Kin Tang

13 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kin Tang United States 8 177 71 44 40 40 14 255
Jennifer Tavares Jacon Freitas Brazil 10 124 0.7× 105 1.5× 47 1.1× 51 1.3× 18 0.5× 20 325
Benjamin Wuyts Belgium 7 214 1.2× 77 1.1× 54 1.2× 56 1.4× 17 0.4× 11 341
Patrick J. Jansen United States 8 37 0.2× 23 0.3× 98 2.2× 74 1.9× 91 2.3× 18 262
Mette Grove Denmark 6 173 1.0× 32 0.5× 36 0.8× 34 0.8× 30 0.8× 7 219
Tapon Roy United States 5 191 1.1× 30 0.4× 40 0.9× 91 2.3× 41 1.0× 10 350
Peinan Sun China 3 169 1.0× 34 0.5× 31 0.7× 40 1.0× 41 1.0× 8 208
Matthew A. Augustine United States 7 276 1.6× 148 2.1× 79 1.8× 40 1.0× 66 1.6× 13 364
Sara Carlert Sweden 6 392 2.2× 159 2.2× 66 1.5× 78 1.9× 86 2.1× 12 512
Hanlin Li China 9 49 0.3× 41 0.6× 71 1.6× 124 3.1× 47 1.2× 23 266
Zhongqing Wang China 11 37 0.2× 28 0.4× 22 0.5× 130 3.3× 16 0.4× 50 409

Countries citing papers authored by Kin Tang

Since Specialization
Citations

This map shows the geographic impact of Kin Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kin Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kin Tang more than expected).

Fields of papers citing papers by Kin Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kin Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kin Tang. The network helps show where Kin Tang may publish in the future.

Co-authorship network of co-authors of Kin Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Kin Tang. A scholar is included among the top collaborators of Kin Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kin Tang. Kin Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lynch, Patrick M., et al.. (2024). Acceleration of new medicines–CMC lessons learned from emergency use authorizations. SHILAP Revista de lepidopterología. 10(1).
2.
Cauchon, Nina S., Xiaohong Chen, Tao Li, et al.. (2022). Meeting report: Advancing accelerated regulatory review with Real-Time Oncology Review (RTOR), Project Orbis, and the Product Quality Assessment Aid. SHILAP Revista de lepidopterología. 8(1). 19–19. 2 indexed citations
3.
4.
Roberts, Scott W., et al.. (2021). Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology Industries. The AAPS Journal. 23(4). 94–94. 2 indexed citations
5.
Ming, Long Chiau, Kin Tang, Hitesh Chokshi, & Nikoletta Fotaki. (2019). Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation. AAPS PharmSciTech. 20(3). 113–113. 19 indexed citations
6.
Chokshi, Hitesh, et al.. (2013). Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state. European Journal of Pharmaceutics and Biopharmaceutics. 84(3). 633–641. 49 indexed citations
7.
Fotaki, Nikoletta, William E. Brown, Hitesh Chokshi, et al.. (2013). Rationale for Selection of Dissolution Media: Three Case Studies. Dissolution Technologies. 20(3). 6–13. 1 indexed citations
8.
Fotaki, Nikoletta, William E. Brown, Hitesh Chokshi, et al.. (2013). Rationale for Selection of Dissolution Media: Three Case Studies. Dissolution Technologies. 20(3). 6–13. 20 indexed citations
9.
Shah, Navnit H., Harpreet Sandhu, Wantanee Phuapradit, et al.. (2012). Development of novel microprecipitated bulk powder (MBP) technology for manufacturing stable amorphous formulations of poorly soluble drugs. International Journal of Pharmaceutics. 438(1-2). 53–60. 57 indexed citations
10.
Polli, James E., Jack Cook, Barbara M. Davit, et al.. (2012). Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence. The AAPS Journal. 14(3). 627–638. 15 indexed citations
11.
Jantratid, Ekarat, et al.. (2007). Designing biorelevant dissolution tests for lipid formulations: Case example – Lipid suspension of RZ-50. European Journal of Pharmaceutics and Biopharmaceutics. 69(2). 776–785. 60 indexed citations
12.
Tang, Kin, et al.. (1993). Stability of Ceftriaxone Sodium in Infusion-pump Syringes. American Journal of Health-System Pharmacy. 50(10). 2092–2094. 1 indexed citations
13.
Tang, Kin, et al.. (1991). The determination of 2,6-diisopropylphenol (propofol) in an oil in water emulsion dosage form by high-performance liquid chromatography and by second d. Journal of Pharmaceutical and Biomedical Analysis. 9(6). 501–506. 18 indexed citations
14.
Tang, Kin, et al.. (1991). Effect of Syringe Filter and i.v. Administration Set on Delivery of Propofol Emulsion. American Journal of Health-System Pharmacy. 48(12). 2627–2630. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Tavares Jacon Freitas Breakdown of academic impact, for papers by Benjamin Wuyts Breakdown of academic impact, for papers by Patrick J. Jansen Breakdown of academic impact, for papers by Mette Grove Breakdown of academic impact, for papers by Tapon Roy Breakdown of academic impact, for papers by Peinan Sun Breakdown of academic impact, for papers by Matthew A. Augustine Breakdown of academic impact, for papers by Sara Carlert Breakdown of academic impact, for papers by Hanlin Li Breakdown of academic impact, for papers by Zhongqing Wang
Rankless by CCL
2026